Virulizin FDA Approval Status
FDA Approved: No
Brand name: Virulizin
Company: Lorus Therapeutics Inc.
Treatment for: Pancreatic Cancer
Virulizin is a biologic response modifier in development for the treatment of pancreatic cancer.
Development timeline for Virulizin
| Date | Article |
|---|---|
| Jun 13, 2005 | U.S. FDA Agrees to Rolling New Drug Application for Virulizin |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
